'Yes! We Can End TB!' — World Health Organization (WHO) Calls for Accelerated Implementation of the Multisectoral Accountability Framework for the Tuberculosis (TB) Response
On 24 March 1882, Dr Robert Koch announced to the Berlin Physiological Society that he had discovered Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB). This landmark discovery revolutionised the understanding and treatment of TB. By isolating and culturing the microorganism, Dr Koch laid the foundation for effective diagnostic and treatment methods that have since saved countless lives. In recognition of his pioneering work, he was awarded the Nobel Prize in Physiology or Medicine in 1905.
Each year on 24 March, countries around the world commemorate World Tuberculosis Day (WTD)—not only to honour Dr Koch's achievement but also to raise awareness of the devastating health, social and economic consequences of TB, and to accelerate efforts to end the global TB epidemic.
Despite significant advances, TB remains a major public health challenge in Ethiopia, as in many low- and middle-income countries. According to the 2024 WHO Global TB Report, Ethiopia is among the 30 high-burden countries for both TB and TB/HIV. The estimated TB incidence is 146 per 100,000 population, with 8.3% of TB patients co-infected with HIV. In 2023, TB-related mortality among HIV-negative individuals was estimated at 19 per 100,000 population.
Ethiopia commemorated World TB Day on 23 March 2025 in Arba Minch City under the global theme: 'Yes! We Can End TB! Commit, Invest, Deliver!' The event featured a range of activities, including the Tuberculosis Research Advisory Council (TRAC) Conference, as well as vibrant social mobilisation and awareness-raising campaigns. Participants included senior officials from the Federal Ministry of Health (FMoH), the South Ethiopia Regional Health Bureau, Arba Minch City Administration, Arba Minch University, WHO, the German Leprosy and Tuberculosis Relief Association (GLRA), the Armauer Hansen Research Institute (AHRI), and other partners and stakeholders.
Tuberculosis Research Advisory Council (TRAC) Conference
Ethiopia has adopted WHO's End TB Strategy, which aims to eliminate TB by 2035. The strategy's third pillar emphasises intensified research and innovation. To support this, the WHO Global TB Programme (GTP) developed the Global Action Framework for TB Research (GAF) to advance TB research at national and global levels, especially in low- and middle-income countries.
The framework promotes the development of country-specific TB research plans, strengthens research capacity, and fosters the establishment of national research networks that link TB control programmes with academic and research institutions.
Ethiopia's National TB Research Advisory Council (TRAC) was established in 2001 with support from WHO. For nearly two decades, TRAC has provided technical guidance to the National Tuberculosis Programme and the FMoH. It has played a vital role in advancing operational research on TB prevention, care and control, while serving as a platform for collaboration between researchers and national authorities.
This year, TRAC held its 19th Annual Conference from 21 to 22 March 2025 in Arba Minch, South Ethiopia, under the theme: 'Yes! We Can End TB! Commit, Invest, Deliver!'
In his keynote address, Dr Owen L. Kaluwa, WHO Representative to Ethiopia, commended the country's progress in TB control but underscored the need to close critical gaps. He noted that treatment coverage for new TB and multidrug-resistant TB (MDR-TB) cases stood at approximately 72% and 31%, respectively. Alarmingly, one third of all estimated TB cases and two thirds of MDR-TB cases still lack access to quality care.
Recognising TB as both a health issue and a broader development challenge, Dr Kaluwa called for strengthened collaboration across sectors. He urged expedited implementation of the Multisectoral Accountability Framework for TB (MAF-TB), which Ethiopia launched two years ago.
He also highlighted a 60% funding gap in Ethiopia's TB response, as reported in the 2024 Global TB Report, warning that global funding uncertainties could widen this gap—potentially delaying progress towards the End TB targets.
Dr Kaluwa emphasised the importance of prioritising domestic investment in TB prevention and care, increasing awareness and community education, and advocating for policies that support TB control. He called for stronger political commitment, effective multisectoral coordination, and robust accountability mechanisms. In addition, he encouraged the adoption and expansion of global innovations and tools to accelerate TB control and urged greater support for local research to generate context-specific evidence for decision-making.
Opening the research conference, H.E. Dr Dereje Duguma, State Minister of Health, acknowledged the achievements of Ethiopia's national TB programme, including the scale-up of WHO-recommended rapid diagnostic tools—now exceeding 900 units nationwide—which have significantly improved TB case detection.
Dr Dereje stressed the importance of reinforcing the MAF-TB to drive coordinated, multisectoral efforts. During the event, he presented certificates of recognition to healthcare workers and professionals for their long-standing contributions to TB prevention and care in Ethiopia. He also awarded the highest honours to Dr Abraham Assefa for his outstanding contributions to TB control and to TRAC.
Over the course of the two-day conference, 27 research abstracts—selected from more than 100 submissions to the TRAC Secretariat—were presented and discussed, offering valuable insights into national TB priorities and further strengthening the country's TB research agenda.
Distributed by APO Group on behalf of World Health Organization (WHO) - Ethiopia.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
14 hours ago
- Zawya
United Nations Office for Project Services (UNOPS) Executive Director to visit Ethiopia, Somalia and Sudan
Jorge Moreira da Silva, UN Under-Secretary-General and UNOPS Executive Director, is scheduled to visit the Africa region, in a five-day visit that will take him to Ethiopia, Somalia and Sudan. During his visit, Mr. Moreira da Silva will meet national authorities and development partners. He will discuss the practical solutions that UNOPS offer to partners to maximize the impact of their humanitarian, development and peace operations ―all in support of the Sustainable Development Goals. The visit also aims at getting a better understanding of the needs on the ground, and how UNOPS can scale operations to respond. UNOPS ongoing support in the region includes: In Sudan, where half of the population ―some 25 million people― need humanitarian assistance and protection, UNOPS is strengthening health infrastructure, improving access to clean, safe water, supporting peacekeeping operations to protect civilians, and facilitating a more sustainable and equitable use of natural resources. In Somalia, UNOPS works to strengthen the capacity of Somali institutions and supports partners in a range of sectors, such as health, governance, peace and security. We work to support reconstruction and state-building through disaster preparedness planning, crisis recovery, climate-resilient infrastructure and strengthening of the security sector. In Ethiopia, UNOPS works with partners to support national and international development priorities. Over the years, with our partners, we have helped strengthen health and education systems and supported food security. This includes environmentally friendly solutions and innovative models to modernize Ethiopia's agriculture sector, provide clean energy to off-grid areas and improve health services across the country. Distributed by APO Group on behalf of United Nations - Ethiopia.
Zawya
6 days ago
- Zawya
Ethiopia Secures Global Laboratory Accreditation to Boost Animal Products, and Inputs Quality and Safety
In a major stride towards enhancing public health and regional trade, the Animal Products and Inputs Quality Testing Center (APIQTC) under the Ethiopian Agricultural Authority (EAA) has officially earned ISO/IEC 17025:2017 accreditation. This international certification, awarded on 25 April 2025 during a high-level event at Haile Grand Hotel in Addis Ababa, Ethiopia, recognized the Center's capacity to perform laboratory tests to globally accepted standards. This milestone strengthens Ethiopia's ability to ensure the safety and quality of animal products and inputs, prevent and contain the spread of antimicrobial resistance (AMR), and safeguard human, animal, and environmental health through a One Health approach. Accreditation to ISO/IEC 17025:2017 confirms the APIQTC's technical competence in performing on thirteen parameters on veterinary pharmaceutical quality; Aflatoxin residue monitoring in animal source food and feed, and microbiological analysis. These functions are vital for independently verifying animal products and inputs quality and adherence to international trade requirements and supporting public confidence. In a country where livestock plays a central role in the economy, such capabilities are indispensable for market access, trade, and sustainable agricultural development. FAO's Strategic Role The Food and Agriculture Organization of the United Nations (FAO) in Ethiopia was recognized during the ceremony for its long-standing health system strengthening support of the regulatory frameworks and laboratory capacity of APIQTC. FAO's technical and logistical assistance was instrumental in achieving this global standard. Minister of Agriculture, H.E. Dr. Girma Amente, praised the achievement during the event, stating that, 'ISO accreditation is critical for Ethiopia's agricultural sustainability and public health security. This international recognition reflects our commitment to quality assurance and our readiness to meet global food safety standards.' Looking Ahead More than a technical certification, this accreditation marks a turning point for Ethiopia's livestock and agriculture sectors. It signals the country's growing capacity to independently ensure animal products and inputs safety and quality, mitigate Antimicrobial Resistance (AMR) threats, and meet the demands of markets. Aligned with FAO's global vision for better production, better nutrition, a better environment, and a better life, this achievement positions Ethiopia to move forward with confidence toward sustainable agrifood systems transformation. Distributed by APO Group on behalf of Food and Agriculture Organization of the United Nations (FAO): Regional Office for Africa.
Khaleej Times
03-06-2025
- Khaleej Times
From Nigeria to Pakistan, TB testing 'in a coma' after US aid cuts
A t a tense meeting in Nigeria's capital Abuja, health workers poured over drug registers and testing records to gauge whether US aid cuts would unravel years of painstaking work against tuberculosis in one of Africa's hardest hit countries. For several days in May, they brainstormed ways to limit the fallout from a halt to US funding for the TB Local Network (TB LON), which delivers screening, diagnosis and treatment. "To tackle the spread of TB, you must identify cases and that is in a coma because of the aid cuts," said Ibrahim Umoru, coordinator of the African TB Coalition civil society network, who was at the Abuja meeting. "This means more cases will be missed and disaster is looming." This desperate struggle to save endangered programmes is being replicated from the Philippines to South Africa as experts warn that U.S. aid cuts risk reviving a deadly infectious disease that kills around one million people every year. President Donald Trump's gutting of the U.S. Agency for International Development has put TB testing and tracing on hold in Pakistan and Nigeria, stalled vital research in South Africa and left TB survivors lacking support in India. The World Health Organisation says "the drastic and abrupt cuts in global health funding" threaten to reverse the gains made by global efforts to fight the disease - namely 79 million lives saved since 2000 - with rising drug resistance and conflicts exacerbating the risks. In Nigeria, TB LON is in the firing line. The project was set up in 2020, during Trump's first term, and received $45 million worth of funding from USAID. The U.S. development agency said at the time it was committed to a "TB free Nigeria". Five years later and with the same president back in charge but now with a more radical "America first" agenda, USAID support for TB LON's community testing work was terminated in February, according to a TB LON official. The official did not want to be named because he was not authorised to speak on behalf of the project. 'HARD WORK IN JEOPARDY' TB kills 268 Nigerians every day and cases have historically been under-reported increasing the risk of transmission. If one case is missed, that person can transmit TB to 15 people over a year, according to the World Health Organization. The Thomson Reuters Foundation spoke to half a dozen health workers who collect TB test samples for TB LON but had stopped doing so in January due to the U.S. aid freeze. Between 2020-2024, TB LON screened around 20 million people in southwestern states in Nigeria, and more than 100,000 patients were treated as a result. "All that hard work is in jeopardy if we don't act quickly," Umoru said, adding that non-profits working with TB LON had laid off more than 1,000 contract workers who used to do TB screening. Nigeria's health ministry did not respond to request for comment on the effect of the USAID cuts on TB programmes. In March, First Lady Oluremi Tinubu declared TB a national emergency and donated 1 billion naira ($630,680) to efforts to eradicate the disease by 2030. In South Africa, medical charity Médecins Sans Frontières (MSF) said TB and HIV programmes had been disrupted across the country, making patient tracking and testing more difficult, according to a statement sent to the Thomson Reuters Foundation. South Africa had a TB incidence rate of 427 per 100,000 people in 2023, government data showed, down 57% from 2015. TB-related deaths in South Africa dropped 16% over that period, the data showed. Minister of Health Aaron Motsoaledi said in May that the government would launch an End TB campaign to screen and test 5 million people, and was also seeking new donor funding. "Under no circumstances will we allow this massive work performed over a period of more than a decade and half to collapse and go up in smoke," he said at the time, referring to efforts to tackle TB and HIV. BLOW TO CRITICAL RESEARCH South Africa is also a hub for research into both TB and HIV and the health experts say funding cuts risk derailing this vital work. The Treatment Action Group (TAG), a community-based research and policy think tank, says around 39 clinical research sites and at least 20 TB trials and 24 HIV trials are at risk. "Every major TB treatment and vaccine advance in the past two decades has relied on research carried out in South Africa," said TAG TB project co-director Lindsay McKenna in a March statement. People struggling with poor nutrition and those living with HIV -- the latter affects 8 million people in South Africa -- were also more at risk of contracting TB as aid cuts made them more vulnerable by derailing nutrition programmes, community outreach and testing, said Cathy Hewison, head of MSF's TB working group. "It's the number one killer of people with HIV," she said. In the Philippines, U.S. cuts have disrupted TB testing in four USAID-funded projects, and affected the supply of drugs, Stop TB Partnership, a U.N.-funded agency said. "The country has a nationwide problem with recurrent drug shortages, which is leading to a direct impact on efforts to eliminate TB," said Ghazali Babiker, head of mission for MSF Philippines. In Pakistan, which sees 510,000 TB infections each year, MSF said US cuts had disrupted TB screening in communities and other services in the hard-hit southeastern province of Sindh. "We are worried that the U.S. funding cuts that have impacted the community-based services will have a disproportionate effect on children, leading to more children with TB and more avoidable deaths," said Ei Hnin Hnin Phyu, medical coordinator with MSF in Pakistan.
